Overview

A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma

Status:
Completed
Trial end date:
2020-04-15
Target enrollment:
Participant gender:
Summary
This research is studying how safe and effective all-trans retinoic acid (ATRA), is to treat advanced adenoid cystic carcinoma (ACC).
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
ACCRF
The V Foundation
Treatments:
Tretinoin